Barnaby Kelly is a member of the Developmental and Cancer Biology Research group in the Centre for Cancer Research.
Areas of interest
Childhood cancer Lung cancer Sarcoma
Research group
Developmental and Cancer Biology
Barnaby Kelly
Degree:
PhD student
Research Group:
Research Centre:
Area of study:
Paeditric Osteosarcoma
Supervisors:
Year of enrolment:
2024
Why did you choose Hudson Institute and your research group?
I had an interest for paediatric cancer from my honours research that focused on dog osteosarcoma which exposed me through the literature to the negative outcomes associated with children. It was then I found and reached out to my supervisor Associate Professor Jason Cain. Through discussions about the project and the aspirations of the lab with respect to sarcoma research it made it an easy decision
What is your research about and what do you hope to achieve?
My research focus is on paediatric Osteosarcoma, the most common form of bone cancer in children and adolescents. It is a very aggressive disease that is unaided by the high rates of relapse and metastasis, which relate in part to treatment resistance. My work mainly focuses on investigating the genetic mechanisms that drives resistance to a particular chemotherapy called cisplatin. I hope to identify mechanisms that drive this resistance, provide a rationale for future drug development and repurpose therapies that can be applied to restore effective treatment, which will lead to more beneficial patient outcomes.
What is it like being a student at Hudson Institute?
The environment in Hudson is very welcoming; there are a lot of support networks in place for new students, and the student committee implements enjoyable social activities. Not long after when I started, we had a student retreat which was fun based out in the Yarra Valley and then the winter ball we had in July was also a really fun social activity.